Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 576

    1.

    Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study.

    Monami M, Cresci B, Colombini A, Pala L, Balzi D, Gori F, Chiasserini V, Marchionni N, Rotella CM, Mannucci E.

    Diabetes Care. 2008 Feb;31(2):199-203. Epub 2007 Nov 16.PMID: 18024851 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk.

    Vestergaard P, Rejnmark L, Mosekilde L.

    Diabetologia. 2005 Jul;48(7):1292-9. Epub 2005 May 21.PMID: 15909154 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.

    Koro CE, Bowlin SJ, Weiss SR.

    Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):697-703.PMID: 15654719 [PubMed - indexed for MEDLINE]Related articles

    4.

    Use of thiazolidinediones and fracture risk.

    Meier C, Kraenzlin ME, Bodmer M, Jick SS, Jick H, Meier CR.

    Arch Intern Med. 2008 Apr 28;168(8):820-5.PMID: 18443256 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.

    Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR.

    Diabetes Care. 2008 Nov;31(11):2086-91. Epub 2008 Sep 9.PMID: 18782901 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

    Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group.

    Diabetes Care. 2008 May;31(5):845-51. Epub 2008 Jan 25.PMID: 18223031 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Risk factor management in stable, insulin-treated patients with Type 2 diabetes: the Diabetes Outcomes in Veterans Study.

    Murata GH, Shah JH, Wendel CS, Hoffman RM, Adam KD, Bokhari SU, Solvas PA, Duckworth WC.

    J Diabetes Complications. 2003 Jul-Aug;17(4):186-91.PMID: 12810241 [PubMed - indexed for MEDLINE]Related articles

    9.

    Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study.

    Monami M, Lamanna C, Pala L, Bardini G, Cresci B, Francesconi P, Balzi D, Marchionni N, Rotella CM, Mannucci E.

    Exp Clin Endocrinol Diabetes. 2008 Mar;116(3):184-9. Epub 2008 Feb 14.PMID: 18273755 [PubMed - indexed for MEDLINE]Related articles

    10.

    Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia.

    ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW.

    Diabetes Care. 2000 Oct;23(10):1467-71.PMID: 11023138 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Antidiabetic therapies affect risk of pancreatic cancer.

    Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL.

    Gastroenterology. 2009 Aug;137(2):482-8. Epub 2009 Apr 16.PMID: 19375425 [PubMed - indexed for MEDLINE]Related articles

    12.

    Diabetes-related complications, glycemic control, and falls in older adults.

    Schwartz AV, Vittinghoff E, Sellmeyer DE, Feingold KR, de Rekeneire N, Strotmeyer ES, Shorr RI, Vinik AI, Odden MC, Park SW, Faulkner KA, Harris TB; Health, Aging, and Body Composition Study.

    Diabetes Care. 2008 Mar;31(3):391-6. Epub 2007 Dec 4. Erratum in: Diabetes Care. 2008 May;31(5):1089. PMID: 18056893 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?

    Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.

    Pharmacoepidemiol Drug Saf. 2003 Mar;12(2):121-7.PMID: 12642975 [PubMed - indexed for MEDLINE]Related articles

    15.

    Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting.

    Maru S, Koch GG, Stender M, Clark D, Gibowski L, Petri H, White AD, Simpson RJ Jr.

    Diabetes Care. 2005 Jan;28(1):20-6.PMID: 15616228 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Does diabetes increase the risk for fractures after solid organ transplantation? A nested case-control study.

    Rakel A, Sheehy O, Rahme E, Lelorier J.

    J Bone Miner Res. 2007 Dec;22(12):1878-84.PMID: 17680725 [PubMed - indexed for MEDLINE]Related articles

    18.

    Haemoglobin A1c goal attainment in relation to dose in patients with diabetes mellitus taking metformin: a nested, case-control study.

    Penning-van Beest FJ, Wolffenbuttel BH, Herings RM.

    Clin Drug Investig. 2008;28(8):487-93.PMID: 18598094 [PubMed - indexed for MEDLINE]Related articles

    19.

    A cohort study of thiazolidinediones and fractures in older adults with diabetes.

    Solomon DH, Cadarette SM, Choudhry NK, Canning C, Levin R, Stürmer T.

    J Clin Endocrinol Metab. 2009 Aug;94(8):2792-8. Epub 2009 May 26.PMID: 19470635 [PubMed - indexed for MEDLINE]Related articles

    20.

    Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey.

    Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B.

    Diabet Med. 2006 Jul;23(7):750-6.PMID: 16842479 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data